Sfoglia per Autore
Role of BRCA mutations in cancer treatment with poly(ADP-ribose) polymerase (PARP) inhibitors
2018-01-01 Faraoni, I; Graziani, G
Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders
2019-01-01 Faraoni, I; Giansanti, M; Voso, Mt; Lo-Coco, F; Graziani, G
Cytotoxicity and differentiating effect of the poly(ADP-ribose) polymerase inhibitor olaparib in myelodysplastic syndromes
2019-01-01 Faraoni, I; Consalvo, Mi; Aloisio, F; Fabiani, E; Giansanti, M; Di Cristino, F; Falconi, G; Tentori, L; Di Veroli, A; Curzi, P; Maurillo, L; Niscola, P; Lo-Coco, F; Graziani, G; Voso, Mt
Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies
2019-10-01 Noguera, Ni; Catalano, G; Banella, C; Divona, M; Faraoni, I; Ottone, T; Arcese, W; Voso, Mt
Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line
2019-11-28 Cioccoloni, G; Aquino, A; Notarnicola, M; Caruso, Mg; Bonmassar, E; Zonfrillo, M; Caporali, S; Faraoni, I; Villiva, C; Fuggetta, Mp; Franzese, O
Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers
2020-01-01 Ceci, C; Graziani, G; Faraoni, I; Cacciotti, I
High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients
2021-03-20 Giansanti, M; Karimi, T; Faraoni, I; Graziani, G
Poly(ADP-Ribose) polymerase inhibitors for arsenic trioxide-resistant acute promyelocytic leukemia: synergistic in vitro antitumor effects with hypomethylating agents or high-dose vitamin C
2021-06-01 Giansanti, M; De Gabrieli, A; Prete, Sp; Ottone, T; Divona, Md; Karimi, T; Ciccarone, F; Voso, Mt; Graziani, G; Faraoni, I
Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?
2021-10-01 Franzese, O; Torino, F; Giannetti, E; Cioccoloni, G; Aquino, A; Faraoni, I; Fuggetta, Mp; De Vecchis, L; Giuliani, A; Kaina, B; Bonmassar, E
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia
2022-01-01 Ottone, T; Faraoni, I; Fucci, G; Divona, M; Travaglini, S; De Bellis, E; Marchesi, F; Angelini, Df; Palmieri, R; Gurnari, C; Giansanti, M; Nardozza, Am; Montesano, F; Fabiani, E; Lindfors Rossi, El; Cerretti, R; Cicconi, L; De Bardi, M; Catanoso, Ml; Battistini, L; Massoud, R; Venditti, A; Voso, Mt
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2018 | Role of BRCA mutations in cancer treatment with poly(ADP-ribose) polymerase (PARP) inhibitors | Faraoni, I; Graziani, G | Articolo su rivista | |
| 1-gen-2019 | Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders | Faraoni, I; Giansanti, M; Voso, Mt; Lo-Coco, F; Graziani, G | Articolo su rivista | |
| 1-gen-2019 | Cytotoxicity and differentiating effect of the poly(ADP-ribose) polymerase inhibitor olaparib in myelodysplastic syndromes | Faraoni, I; Consalvo, Mi; Aloisio, F; Fabiani, E; Giansanti, M; Di Cristino, F; Falconi, G; Tentori, L; Di Veroli, A; Curzi, P; Maurillo, L; Niscola, P; Lo-Coco, F; Graziani, G; Voso, Mt | Articolo su rivista | |
| 1-ott-2019 | Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies | Noguera, Ni; Catalano, G; Banella, C; Divona, M; Faraoni, I; Ottone, T; Arcese, W; Voso, Mt | Articolo su rivista | |
| 28-nov-2019 | Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line | Cioccoloni, G; Aquino, A; Notarnicola, M; Caruso, Mg; Bonmassar, E; Zonfrillo, M; Caporali, S; Faraoni, I; Villiva, C; Fuggetta, Mp; Franzese, O | Articolo su rivista | |
| 1-gen-2020 | Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers | Ceci, C; Graziani, G; Faraoni, I; Cacciotti, I | Articolo su rivista | |
| 20-mar-2021 | High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients | Giansanti, M; Karimi, T; Faraoni, I; Graziani, G | Articolo su rivista | |
| 1-giu-2021 | Poly(ADP-Ribose) polymerase inhibitors for arsenic trioxide-resistant acute promyelocytic leukemia: synergistic in vitro antitumor effects with hypomethylating agents or high-dose vitamin C | Giansanti, M; De Gabrieli, A; Prete, Sp; Ottone, T; Divona, Md; Karimi, T; Ciccarone, F; Voso, Mt; Graziani, G; Faraoni, I | Articolo su rivista | |
| 1-ott-2021 | Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment? | Franzese, O; Torino, F; Giannetti, E; Cioccoloni, G; Aquino, A; Faraoni, I; Fuggetta, Mp; De Vecchis, L; Giuliani, A; Kaina, B; Bonmassar, E | Articolo su rivista | |
| 1-gen-2022 | Vitamin C Deficiency in Patients With Acute Myeloid Leukemia | Ottone, T; Faraoni, I; Fucci, G; Divona, M; Travaglini, S; De Bellis, E; Marchesi, F; Angelini, Df; Palmieri, R; Gurnari, C; Giansanti, M; Nardozza, Am; Montesano, F; Fabiani, E; Lindfors Rossi, El; Cerretti, R; Cicconi, L; De Bardi, M; Catanoso, Ml; Battistini, L; Massoud, R; Venditti, A; Voso, Mt | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile